Skip to main content

Inflammatory Markers Control

Meaning

Inflammatory Markers Control is the clinical objective of reducing the systemic concentrations of pro-inflammatory signaling molecules, particularly high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Chronic, low-grade inflammation, often termed “inflammaging,” is a key driver of age-related decline and hormonal dysregulation, including insulin resistance and reduced testosterone production. Achieving effective control of these markers is a core strategy in longevity medicine to mitigate systemic stress and improve cellular responsiveness to beneficial hormones.